Latest Partnerships And Deals News

Proteomics International has secured a US patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma, marking a critical step toward commercialisation in the world’s largest healthcare market.

DroneShield has landed a $49.6 million contract to supply handheld counterdrone systems to a European military customer, with deliveries and payments expected to complete by Q1 2026.

Mineral Resources Limited and POSCO Holdings have agreed to form a $1.2 billion joint venture for their lithium assets, marking a significant step in global lithium supply partnerships. The deal will strengthen MinRes’ balance sheet and deepen ties between Australia and Korea in critical minerals.

Neurizon Therapeutics has been granted a key Australian patent for its lead drug candidate NUZ-001, extending protection for treatments targeting ALS, Alzheimer's, and other neurodegenerative diseases through 2041. This milestone complements earlier US patent grants and sets the stage for upcoming clinical trials.

Opthea Limited has terminated its sozinibercept wet AMD program following Phase 3 trial failures and settled a major funding agreement, setting the stage for a strategic reset.

Lumos Diagnostics has voluntarily suspended its ASX trading pending a market announcement about strategic agreements, signaling potential shifts in its business trajectory.

Proteomics International has achieved a major milestone with the first worldwide patent granted in Japan for its PromarkerEndo blood test, designed to diagnose endometriosis early and accurately.

Alliance Aviation Services has agreed to sell twelve General Electric CF34-10 engines to Beautech Power Systems for approximately USD40.2 million, aiming to reduce inventory and cut net debt without affecting profit guidance.